Accreditation Council for Pharmacy Education
Binghamton University's School of Pharmacy and Pharmaceutical Sciences has been authorized by the Accreditation Council for Pharmacy Education (ACPE) Board of Directors for an on-site evaluation to be scheduled during the fall of 2016 for consideration of Precandidate status. Authorization of an on-site evaluation does not carry with it nor imply an accreditation status. The on-site evaluation is authorized solely for purposes of gathering additional information in furtherance of an accreditation decision. The ACPE Board of Directors will consider Precandidate status at its regularly scheduled meeting in January 2017, following the on-site evaluation. For an explanation of the ACPE accreditation process, consult the Office of the Dean in the School of Pharmacy and Pharmaceutical Sciences or the Accreditation Council for Pharmacy Education, 135 South LaSalle St., Suite 4100, Chicago, Ill., 60503, phone 312-644-3575; fax 312-664-4652; or www.acpe-accredit.org. An explanation of pre-accreditation status is below.
ACPE explanation of Precandidate status
Granting of Precandidate status brings no rights or privileges of accreditation as associated with either Candidate status or Accredited status. Precandidate status indicates only that planning has taken into account ACPE standards and guidelines and suggests reasonable assurance of moving to the next step, that of Candidate status. Since Precandidate status does not create any rights of accreditation under the ACPE standards, it is the opinion of ACPE that graduates of programs of colleges or schools of pharmacy that bear Precandidate status do not meet the educational requirements for licensure.
ACPE explanation of Candidate status
With respect to clarification of the meaning of Candidate status, graduates of a program so designed would, in the opinion of ACPE, have the same rights and privileges of those graduates from an accredited program. The Candidate status denotes a developmental program that is expected to mature in accord with stated plans within a defined time period. It should be underscored, however, that decisions concerning eligibility for licensure by examination or reciprocity reside with the respective state boards of pharmacy in accordance with their state statutes and administrative rules. Should Candidate status be awarded to a program, ACPE would, however, make its position known and make recommendations consistent with that position.
The School of Pharmacy and Pharmaceutical Sciences anticipates matriculating its first pharmacy class in August 2017, pending Precandidate status from ACPE.
Middle States Commission on Higher Education
On January 3, 2017, the Middle States Commission on Higher Education approved the inclusion of the "Professional Practice Degree (Doctor of Pharmacy - Pharm.D.) within the scope of the institution's accreditation."
SUNY Board of Trustees
On March 11, 2015, the School of Pharmacy and Pharmaceutical Sciences received approval from the SUNY Board of Trustees for its plan to confer the Doctor of Pharmacy degree.
New York State Education Department
The New York State Board of Regents approved the PharmD degree on December 13, 2016. The NYS Education Department is expected to register the program when ACPE awards precandidate status, pending in January 2017.